Article
Multiple variants in vascular endothelial growth factor (VEGFA) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCT/EDIC genetics study.
Diabetes - 1 Aug 2007
Al-Kateb Hussam, Mirea Lucia, Xie Xinlei, Sun Lei, Liu Michelle, Chen Hongtao, Bull Shelley B, Boright Andrew P, Paterson Andrew D
Abstract excerpt
OBJECTIVE: We sought to determine if any common variants in the gene for vascular endothelial growth factor (VEGFA) are associated with long-term renal and retinal complications in type 1 diabetes. RESEARCH DESIGN AND METHODS: A total of 1,369 Caucasian subjects with type 1 diabetes from the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study had...
Topics
Join the communities discussing this publication.
